Multiple sclerosis: infectious hypothesis

被引:0
|
作者
E. Granieri
I. Casetta
M. R. Tola
P. Ferrante
机构
[1] Department of Neurology,
[2] University of Ferrara,undefined
[3] I-44100 Ferrara,undefined
[4] Italy,undefined
[5] Don C. Gnocchi Foundation,undefined
[6] IRCCS,undefined
[7] University of Milan,undefined
[8] Milan,undefined
[9] Italy,undefined
来源
Neurological Sciences | 2001年 / 22卷
关键词
Key words Multiple sclerosis; Infections; Risk factors; Epidemiology;
D O I
暂无
中图分类号
学科分类号
摘要
In the search for the etiology of multiple sclerosis (MS), consideration has been given in turn to infectious agents, to genetic markers, and more recently to a combination of genetic and environmental factors, but after over a century of research, a definite conclusion has not been reached. The hypothesis that an infectious agent is responsible for triggering MS is perhaps one of neurology's most enduring notions. Interest in an infectious etiology has waxed and waned over the last two centuries since Pierre Marie first proposed that MS often starts as an infectious process. The possible role of infectious agents has been suggested by: the different geographic gradients in frequency among Caucasians; changes in prevalence due to migration, and the effect of age at migration; the suggestion of epidemics and clusters of cases in some small communities; and the remarkably low degree of concordance in monozygotic twins. The infectious hypothesis is strongly supported by the different temporal patterns of the disease in different geographic areas. Incidence rates have remained stable in some areas, but have changed over time in other regions. On the other hand, the hypothesis is hampered by the lack of evidence for a specific agent, and the weakness of the results of analytical studies that have tested the association between MS and previous infections. Despite these drawbacks, recent studies of a few select pathogens suggest that viral or bacterial infections or reactivations may trigger clinical exacerbations in relapsing-remitting MS.
引用
收藏
页码:179 / 185
页数:6
相关论文
共 50 条
  • [21] Immunogenetic heterogeneity of multiple sclerosis in Sardinia
    S. Sotgiu
    M. Pugliatti
    G. Solinas
    P. Castiglia
    A. Sanna
    G. Rosati
    Neurological Sciences, 2001, 22 : 167 - 170
  • [22] Seasonality of admissions with multiple sclerosis in Scotland
    Handel, Adam E.
    Disanto, Giulio
    Jarvis, Lynne
    McLaughlin, Ryan
    Fries, Anastasia
    Ebers, George C.
    Ramagopalan, Sreeram V.
    EUROPEAN JOURNAL OF NEUROLOGY, 2011, 18 (08) : 1109 - 1111
  • [23] Seasonal variation in multiple sclerosis relapse
    Harding, Katharine
    Tilling, Kate
    MacIver, Claire
    Willis, Mark
    Joseph, Fady
    Ingram, Gillian
    Hirst, Claire
    Wardle, Mark
    Pickersgill, Trevor
    Ben-Shlomo, Yoav
    Robertson, Neil
    JOURNAL OF NEUROLOGY, 2017, 264 (06) : 1059 - 1067
  • [24] Multiple sclerosis in Colombia: A review of the literature
    Miranda-Acuna, Jahir
    Casallas-Vanegas, Adriana
    Mccauley, Jacob
    Castro-Castro, Pedro
    Amezcua, Lilyana
    MULTIPLE SCLEROSIS JOURNAL-EXPERIMENTAL TRANSLATIONAL AND CLINICAL, 2024, 10 (04)
  • [25] Total Hip Arthroplasty in Multiple Sclerosis
    Jandl, Nico Maximilian
    Schmidt, Tobias
    Niemeier, Andreas
    ZEITSCHRIFT FUR ORTHOPADIE UND UNFALLCHIRURGIE, 2020, 158 (02): : 188 - 193
  • [26] Multiple sclerosis: Geoepidemiology, genetics and the environment
    Milo, Ron
    Kahana, Esther
    AUTOIMMUNITY REVIEWS, 2010, 9 (05) : A387 - A394
  • [27] Prognosis of multiple sclerosis: environmental factors
    I. Casetta
    E. Granieri
    Neurological Sciences, 2000, 21 (Suppl 2) : S839 - S842
  • [28] Exogeneous factors in the aetiology of multiple sclerosis
    Granieri, E
    JOURNAL OF NEUROVIROLOGY, 2000, 6 : S141 - S146
  • [29] The prevalence of multiple sclerosis in the world: an update
    G. Rosati
    Neurological Sciences, 2001, 22 : 117 - 139
  • [30] Involvement of gut microbiota in multiple sclerosis-review of a new pathophysiological hypothesis and potential treatment target
    Olejnik, Piotr
    Buczma, Kasper
    Cudnoch-Jedrzejewska, Agnieszka
    Kasarello, Kaja
    IMMUNOLOGIC RESEARCH, 2024, 72 (04) : 554 - 565